The Food and Drug Administration designates as “breakthrough” technologies certain drugs and devices. This designation helps expedite the development and review of therapies intended to treat serious ...
The lifetime economic burden of inaccurate HER2 testing: Comparing false positive and false negative HER2+ early breast cancer patients in the United States. This is an ASCO Meeting Abstract from the ...
Once considered impossible, restoring movement after paralysis is becoming a reality thanks to EU-funded researchers who have developed a device that reconnects the brain to the body. By Alison Jones ...
InnoCaption, a leader in accessible telecommunications since 2016, today announced that it has been selected as winner of the ...
NSE-FAST ® represents the lead program arising from TETmedical’s patented Tethered Enzyme Technology platform, which the Company believes may have broader applications for diagnosis of acute ...
LAS VEGAS--(BUSINESS WIRE)--A team of workers’ compensation experts will showcase innovations in mental health treatment with a groundbreaking, experiential presentation at this year’s National ...